Business Wire
BusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex TimesBusinessLilly shares early Phase 1 findings for FRα-targeting antibody-drug conjugate in platinum-sensitive ovarian cancer at ESMO 2026The Apex TimesBusinessChina’s incremental market-access move reignites attention on global payment networks like MastercardThe Apex TimesBusinessLockheed Martin’s lower valuation versus RTX draws investor comparison, as defense spending remains a key tailwindThe Apex TimesBusinessOpinion piece pits Nvidia against TSMC for a single, five-year AI betThe Apex TimesBusinessNike approves Genon AI system to automate outsole defect checks, rollout planned for 2027The Apex TimesBusinessBroadcom options market shows outsized appetite for a $600-call bet as “AI fears” enter the debateThe Apex TimesBusinessAmazon buys 3M products for data centers, a move analysts say could ripple across the marketThe Apex TimesBusinessBooz Allen Hamilton shares catch a bid after earnings beat and higher full-year adjusted outlookThe Apex TimesBusinessPalantir expands “sovereign AI” push, betting that controlled deployment wins enterprise and government buyersThe Apex TimesBusinessNVIDIA chief Jensen Huang counters the memory-bear narrative as investors rush to reprice AI hardware timelinesThe Apex TimesBusinessElon Musk argues Tesla’s customer demand is driven by Full Self-Driving, not car-by-car specsThe Apex TimesBusinessCostco starts selling an AI smartphone gimbal on member-only shelves, indicating a new push into camera techThe Apex Times
Back to front
Barclays lifts its Nike price target to $45 as Wolfe sees $28, highlighting a wide split in Wall Street views
The Apex Times

THE APEX TIMES

Business/The Apex Times/Oct 23, 5:59 PM EDT

Barclays lifts its Nike price target to $45 as Wolfe sees $28, highlighting a wide split in Wall Street views

A fresh Yahoo Finance roundup points to sharply different valuation calls for Nike, with a $45 target from Barclays and a $28 target from Wolfe, alongside a lower “street” reference level.

Nike stock is drawing a wide range of Wall Street price targets, according to a market update circulated through Yahoo Finance on Oct. 23.

The post cited Nike’s then-current share price around $38 and reported at least two contrasting analyst views. Barclays, as described in the roundup, set a $45 price target, while Wolfe assigned a lower $28 target. The same update also referenced a “street target” near $36, suggesting that most estimates in the broader consensus are clustered below the higher Barclays call.

The roundup further indicated a “target price (mid)” of roughly $90. That figure, presented alongside the more modest $36 street level, implies that the distribution of analyst estimates may be spread out, with some higher calls pulling up a mid-point calculation even as other firms remain cautious.

Analyst price targets are not guidance for near-term results. They generally reflect a model built on assumptions about revenue growth, margins, product demand, inventory, and the discount rate applied to future earnings. Even when individual firms publish different targets, the market often focuses less on the number itself and more on whether any update is tied to a changed outlook for growth and profitability.

For Nike, the valuation debate comes against the backdrop of how consumer athletic brands are typically judged: by the durability of demand for footwear and apparel, the pace of product innovation, and how efficiently the company manages inventory and promotional activity. Changes in these drivers can lead analysts to revise revenue expectations and margin forecasts, which then flow into target prices.

Still, the Oct. 23 roundup does not provide enough detail in the available packet to identify what specific operating assumptions drove Barclays to $45 or Wolfe to $28. It also does not clarify whether either firm referenced particular product lines, regional performance, or changes in guidance. Without those specifics, investors are left to infer only the direction of the valuation calls rather than the underlying catalysts.

What can be said from the figures alone is that the market is not uniform in its expectations for Nike’s value. With targets spanning from the high $20s to the mid-$40s in the firms highlighted, the implied spread suggests differing assessments of Nike’s fundamentals or its risk profile.

The next read-through for investors will likely come from Nike’s own disclosures, such as quarterly results and any commentary on demand, inventory, and profitability. Analysts often update targets after earnings when they can tie their models to reported performance and revised forecasts, so future changes may narrow or widen the gap reflected in this latest roundup.

Why It Matters

  • A broad split in price targets suggests investors are weighing different assumptions about Nike’s growth and profitability prospects.
  • When street consensus sits near $36 while some firms range higher and lower, it can announcement uncertainty around near-term fundamentals and how much upside is already priced in.
  • Large target dispersion can translate into higher sensitivity to earnings commentary, especially on margins and inventory trends.
  • Until analysts’ rationales are known, the market may focus on forthcoming Nike disclosures to validate or challenge the assumptions behind the targets.

Sources

Key Facts

  • The Yahoo Finance roundup cited Nike shares trading around $38 at the time of publication.
  • The post reported a $45 price target from Barclays for Nike.
  • The post reported a $28 price target from Wolfe for Nike.
  • The roundup referenced a broader “street target” around $36.
  • The same update also referenced a “target price (mid)” of roughly $90.

Retail & Consumer Related